Published in Br J Cancer on January 01, 1998
Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol (1998) 2.28
Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc Natl Acad Sci U S A (1998) 1.93
Expression of Tie1, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol (2000) 1.68
Mathematical modeling of tumor-induced angiogenesis. J Math Biol (2004) 1.51
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2. Proc Natl Acad Sci U S A (2003) 1.32
Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol (2001) 1.16
Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms. Life Sci (2012) 1.14
Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma. J Clin Pathol (2003) 1.09
Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol (1998) 1.07
Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype. Oncotarget (2010) 1.05
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). Br J Cancer (2004) 1.00
Lactate engages receptor tyrosine kinases Axl, Tie2, and vascular endothelial growth factor receptor 2 to activate phosphoinositide 3-kinase/Akt and promote angiogenesis. J Biol Chem (2013) 0.99
Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. Blood (2005) 0.97
Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation. Ann Rheum Dis (2000) 0.96
Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J Angiogenes Res (2009) 0.88
Antibody drug-conjugates targeting the tumor vasculature: Current and future developments. MAbs (2010) 0.88
Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors. World J Gastroenterol (2005) 0.85
Vaccines targeting the neovasculature of tumors. Vasc Cell (2011) 0.84
Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer. Cancer Res (2010) 0.83
A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function. Angiogenesis (2008) 0.82
Selective inhibition of the human tie-1 promoter with triplex-forming oligonucleotides targeted to Ets binding sites. Mol Med (2006) 0.80
Use of adenoviral vectors to target chemotherapy to tumor vascular endothelial cells suppresses growth of breast cancer and melanoma. Mol Ther (2010) 0.80
Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells. J Breast Cancer (2016) 0.75
Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med (1995) 26.60
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (1993) 15.70
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell (1996) 13.95
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst (1992) 8.69
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature (1995) 8.12
Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev (1994) 5.90
Blood vessel formation: what is its molecular basis? Cell (1996) 5.54
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (1994) 5.19
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell (1996) 5.10
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res (1995) 4.84
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet (1992) 4.10
Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst (1995) 3.96
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol (1994) 3.48
Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A (1993) 3.37
The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J (1995) 3.16
Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med (1991) 3.15
Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol (1995) 3.06
Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol (1995) 2.96
Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol (1992) 2.72
Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res (1996) 2.58
A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol (1992) 2.34
Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer (1994) 2.24
Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer (1993) 1.88
Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res (1996) 1.86
Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood (1992) 1.65
Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol (1995) 1.60
Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs (1995) 1.58
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res (1993) 1.58
Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene (1993) 1.51
The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene (1993) 1.44
Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum Pathol (1995) 1.39
Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer (1993) 1.36
Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res (1994) 1.28
Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat (1994) 1.24
Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis (1995) 1.16
Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int J Cancer (1995) 1.12
Clinical prognostic significance of tumour angiogenesis. Ann Oncol (1994) 1.11
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst (1996) 1.11
Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene (1993) 1.06
Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. Br J Cancer (1996) 0.94
Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod Pathol (1995) 0.91
Angiogenesis and breast cancer. Hematol Oncol Clin North Am (1994) 0.80
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA (1997) 8.30
Anaerobic biodegradation of phenolic compounds in digested sludge. Appl Environ Microbiol (1983) 6.68
Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet (1998) 5.95
Papers and originals. Br Med J (1976) 5.90
Small-bowel changes in dermatitis herpetiformis. Lancet (1966) 4.49
Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A (1995) 4.31
Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature (2000) 3.78
HLA-DQ and T-cell receptor genes in insulin-dependent diabetes mellitus. Cold Spring Harb Symp Quant Biol (1986) 3.15
BRCA2 mutations in primary breast and ovarian cancers. Nat Genet (1996) 2.91
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Coeliac syndrome in dermatitis herpetiformis. Lancet (1968) 2.73
Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest (1997) 2.68
Ending the routine guinea-pig test. Tubercle (1972) 2.56
The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. EMBO J (2001) 2.52
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
What constitutes an adequate smear in fine-needle aspiration cytology of the breast? Cancer (1997) 2.39
Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst (1998) 2.32
Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys (1995) 2.28
Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci U S A (1991) 2.27
Myelolipoma: CT and pathologic features. Radiology (1998) 2.22
Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res (1991) 2.20
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis (2005) 2.11
Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J Exp Med (1987) 2.09
Bovine tuberculosis in free-ranging white-tailed deer from Michigan. J Wildl Dis (1997) 2.09
The clinical features of chronic vitamin deficiency. A therapeutic trial in geriatric hospital patients. Gerontol Clin (Basel) (1968) 2.09
High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest (1997) 2.09
Effect of lipopolysaccharide mutations and temperature on plasmid transformation efficiency in Pseudomonas aeruginosa. Can J Microbiol (1986) 2.03
A system for the examination of tubercle bacilli and other mycobacteria. Tubercle (1976) 2.00
Cost-effectiveness of treatment of early stage endometrial cancer. Gynecol Oncol (1999) 1.99
Purpura associated with vomiting in pregnancy. Br Med J (1973) 1.98
Diarrhea-associated over-anticoagulation in a patient taking warfarin: therapeutic role of cholestyramine. Vet Hum Toxicol (2000) 1.98
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res (2001) 1.95
Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res (1992) 1.93
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89
Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet (1979) 1.87
Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc Natl Acad Sci U S A (1992) 1.87
The S. pombe cdc16 gene is required both for maintenance of p34cdc2 kinase activity and regulation of septum formation: a link between mitosis and cytokinesis? EMBO J (1993) 1.80
Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. Cancer J Sci Am (1997) 1.79
Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet (1999) 1.78
Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem (1995) 1.78
Cell kinetics in flat (avillous) mucosa of the human small intestine. Gut (1973) 1.76
The use of helical computed tomography in pregnancy for the diagnosis of acute appendicitis. Am J Obstet Gynecol (2001) 1.76
Opium, the religion of the people. Lancet (1985) 1.74
Analysis of vocal disorders with methods from nonlinear dynamics. J Speech Hear Res (1994) 1.70
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol (2001) 1.69
Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg (2012) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Charnley low-friction arthroplasty of the hip. Twenty-year results with cement. J Arthroplasty (1994) 1.66
Small intestine in psoriasis. Br Med J (1967) 1.66
Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis (1998) 1.63
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res (1995) 1.62
Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria. Am Rev Respir Dis (1971) 1.62
Siderophore presence in sputa of cystic fibrosis patients. Infect Immun (1991) 1.61
Classification of Mycobacterium avium and related opportunist mycobacteria met in England and Wales. J Hyg (Lond) (1967) 1.61
Maintenance of p53 alterations throughout breast cancer progression. Cancer Res (1991) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Nonpalpable breast lesions at biopsy. A detailed analysis of radiographic features. Ann Surg (1988) 1.55
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Mycobacterium szulgai--a new pathogen. Tubercle (1972) 1.49
Respiratory abnormalities among grain handlers: a clinical, physiologic, and immunologic study. Am Rev Respir Dis (1977) 1.48
An endogenous inducer of sexual development in Aspergillus nidulans. J Gen Microbiol (1987) 1.46
Iatrogenic duodenal perforations caused by endoscopic biliary stenting and stent migration: an update. Endoscopy (2006) 1.46
Small-intestinal mucosal abnormalities in various skin diseases--fact or fancy? Gut (1970) 1.46
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ (1996) 1.45
Occupation and Kansasii infection in Cardiff residents. Tubercle (1975) 1.45
Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ (1998) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Use of paravertebral block anesthesia in the surgical management of breast cancer: experience in 156 cases. Ann Surg (1998) 1.43
Thin-layer chromatography of mycobacterial lipids as an aid to classification: technical improvements: mycobacterium avium, M. intracellulare (Battey bacilli). Tubercle (1971) 1.43
A pilot study of a system for grading of drainage blebs after glaucoma surgery. J Glaucoma (2004) 1.42
Thymus deficiency in an infant with a chromosome t(18;22)(q12.2;p11.2)pat rearrangement. Clin Genet (1986) 1.42
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ (1994) 1.42
Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg (1995) 1.40
Simian homologues of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci (2001) 1.40
Effect of exercise on milk immunoglobulin A. Med Sci Sports Exerc (1997) 1.39
Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. J Natl Cancer Inst (1994) 1.39
Intraabdominal mesh prosthesis in a canine model. Surg Endosc (1994) 1.38
The cell cycle time in the flat (avillous) mucosa of the human small intestine. Gut (1973) 1.37
Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal. Hernia (2007) 1.36
Harm minimisation for drug misusers. BMJ (1992) 1.35
From the Archives of the AFIP. Mucinous cystic neoplasms of the pancreas: radiologic-pathologic correlation. Radiographics (1998) 1.35
Thin-layer chromatography of mycobacterial lipids as an aid to classification; Mycobacterium kansasii; and Mycobacterium marinum (balnei). Tubercle (1966) 1.35
Effect of growth temperature on the lipids, outer membrane proteins, and lipopolysaccharides of Pseudomonas aeruginosa PAO. J Bacteriol (1987) 1.34
HL-A antigen type and small-intestinal disease in dermatitis herpetiformis. Lancet (1973) 1.34
Cell cycle control of BRCA2. Cancer Res (1996) 1.32
Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol (2000) 1.31
M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene (1996) 1.31
Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide. Proc Natl Acad Sci U S A (1987) 1.31
Improvement of drg-sensitivity tests on tubercle bacilli. Tubercle (1970) 1.31
Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery (1991) 1.31
Mycobacterium szulgai-a new pathogen. Serologic identification and report of five new cases. Am Rev Respir Dis (1973) 1.29
The activity of S.pombe DSC-1-like factor is cell cycle regulated and dependent on the activity of p34cdc2. EMBO J (1993) 1.29
Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1. J Virol (1999) 1.28
Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg (1993) 1.27